Established during 2000, the Nebraska Center for Virology (NCV;P20RR015635) is a multi-institutional, interdisciplinary center linking the virology expertise and resources at Nebraska's major biomedical research institutions: the University of Nebraska-Lincoln, the University of Nebraska Medical Center, and Creighton University. NCV investigators study human, animal, and plant viruses;their collective expertise presents a national strength and an exceptional opportunity to collaborate on model systems expected to lead to new approaches to understand and treat diseases threatening human health and economic well-being. Following nine years of COBRE program support, the NCV is developing a global research and training presence, and establishing an interdisciplinary research program addressing fundamental questions about infectious agents and their host interactions and creating an environment that is producing a new generation of innovative researchers with a broad knowledge of virology. COBRE support has allowed the Center to establish a critical mass of focused virology expertise and resources on each participating campus;however, to become an independent center, the NCV must bolster its interdisciplinary and cross-campus collaborations and implement a sustainability plan for its core facilities. In addition, several promising junior faculty conducting highly meritorious research continue to need NCV support and mentoring to gain independence. Additional capacity built through Phase III COBRE funding will enable the NCV to realize its strategic plan and achieve its long-term vision: to become an internationally recognized center of research excellence, with outstanding core facilities that serve IDeA, regional, and international scientific communities. This vision will be realized by completing three specific aims: 1) increase the research productivity and external funding potential of NCV faculty by continuing an effective mentoring program for junior faculty, sponsoring a pilot project program, and continuing support for four essential core facilities (administrative, flow cytometry, microscopy, and proteomics);2) strengthen the NCV's focus on translational research and virology research training and education through new partnerships and programs to share viral immunology and molecular virology expertise and scientific resources with researchers, clinicians, and students globally;and 3) emerge from COBRE Phase III funding as a self-sustaining center of research excellence in virology by diversifying the NCV's external research funding portfolio through increased individual-investigator and collaborative grant productivity.

Public Health Relevance

Phase III COBRE funding will ideally position the Nebraska Center for Virology to provide the infrastructure support needed to increase understanding of the molecular mechanisms by which different viral agents establish persistent infection, interact with the host, are transmitted from one host to another, and cause disease - with the ultimate goal of contributing to new strategies to treat and prevent such infections.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Program Officer
Liu, Yanping
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Nebraska Lincoln
Schools of Arts and Sciences
United States
Zip Code
Periyasamy, Palsamy; Liao, Ke; Kook, Yeon Hee et al. (2018) Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling. Mol Neurobiol 55:3196-3210
Fan, Wenjin; Demers, Andrew James; Wan, Yanmin et al. (2018) Altered Ratio of T Follicular Helper Cells to T Follicular Regulatory Cells Correlates with Autoreactive Antibody Response in Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Immunol 200:3180-3187
Thrash, Courtney; Welch-Lazoritz, Melissa; Gauthier, Gertrude et al. (2018) Rural and urban injection drug use in Puerto Rico: Network implications for human immunodeficiency virus and hepatitis C virus infection. J Ethn Subst Abuse 17:199-222
Tso, For Yue; Kang, Guobin; Kwon, Eun Hee et al. (2018) Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome. PLoS One 13:e0201325
Abadie, R; Gelpi-Acosta, C; Davila, C et al. (2018) ""It Ruined My Life"": The effects of the War on Drugs on people who inject drugs (PWID) in rural Puerto Rico. Int J Drug Policy 51:121-127
Fang, Qiwen; Wang, Xiaoyi; Liu, Zhenqiu et al. (2018) Seroprevalence of human herpesvirus 8 and its impact on the hemoglobin level in patients of end stage of renal diseases. J Med Virol 90:338-343
Sharma, Anup D; Wiederin, Jayme; Uz, Metin et al. (2017) Proteomic analysis of mesenchymal to Schwann cell transdifferentiation. J Proteomics 165:93-101
Zhou, Yan; Liu, Jianuo; Xiong, Huangui (2017) HIV-1 Glycoprotein 120 Enhancement of N-Methyl-D-Aspartate NMDA Receptor-Mediated Excitatory Postsynaptic Currents: Implications for HIV-1-Associated Neural Injury. J Neuroimmune Pharmacol 12:314-326
Hong, Jung J; Silveira, Eduardo L di Volpe; Amancha, Praveen K et al. (2017) Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation. AIDS 31:1819-1824
Speciale, Immacolata; Agarkova, Irina; Duncan, Garry A et al. (2017) Structure of the N-glycans from the chlorovirus NE-JV-1. Antonie Van Leeuwenhoek 110:1391-1399

Showing the most recent 10 out of 245 publications